Trichostatin A enhances differentiation of human induced pluripotent stem cells to cardiogenic cells for cardiac tissue engineering

Stem Cells Translational Medicine

Volumn 2, Issue 9, 2013, Pages 715-725

  Lim, Shiang Y ^a,b   Sivakumaran, Priyadharshini ^a   Crombie, Duncan E ^b,c   Dusting, Gregory J ^a,b,c   Pébay, Alice ^b,c   Dilley, Rodney J ^d  

^a O'Brien Institute   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cardiac differentiation; Cardiac tissue engineering; Induced pluripotent stem cell; Trichostatin A

Indexed keywords

ACTIVIN A; ALPHA ACTIN; BONE MORPHOGENETIC PROTEIN 4; CALCIUM; CARBACHOL; GROWTH FACTOR; ISOPRENALINE; MYOSIN HEAVY CHAIN; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5; TRICHOSTATIN A; TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EMBRYOID BODY; GENE EXPRESSION; HEART MUSCLE CELL; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE TEST; MALE; MICROELECTRODE; NONHUMAN; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; RAT; RNA EXTRACTION; TISSUE ENGINEERING; VIDEO MICROSCOPY;

IPS; RATTUS;

EID: 84883350552     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2012-0161     Document Type: Article

References (32)

1. Lloyd-Jones D, Adams R, Carnethon M et al. Heart disease and stroke statistics-2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119: e21-e181
2. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676
3. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318: 1917-1920
4. Burridge PW, Keller G, Gold JD et al. Production of de novo cardiomyocytes: Human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell 2012;10:16-28
5. Mummery CL, Zhang J, Ng ES et al. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: A methods overview. Circ Res 2012;111: 344-358
6. Minami I, Yamada K, Otsuji TG et al. A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine- and xeno-free conditions. Cell Rep 2012;2:1448-1460
7. Kawamura T, Ono K, Morimoto T et al. Acetylation of GATA-4 is involved in the differentiation of embryonic stem cells into cardiac myocytes. J Biol Chem 2005;280:19682-19688
8. Hosseinkhani M, Hasegawa K, Ono K et al. Trichostatin A induces myocardial differentiation of monkey ES cells. Biochem Biophys Res Commun 2007;356:386-391
9. Kaichi S, Hasegawa K, Takaya T et al. Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice. Cardiovasc Res 2010;88:314-323
10. Vanhaecke T, Papeleu P, Elaut G et al. Trichostatin A-like hydroxamate histone deacetylase inhibitors as therapeutic agents: Toxicological point of view. Curr Med Chem 2004;11:1629-1643
11. Liu J, Verma PJ, Evans-Galea MV et al. Generation of induced pluripotent stem cell lines from Friedreich ataxia patients. Stem Cell Rev 2011;7:703-713
12. Zwi L, Caspi O, Arbel G et al. Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 2009;120:1513-1523
13. Lim SY, Hsiao ST, Lokmic Z et al. Ischemic preconditioning promotes intrinsic vascularization and enhances survival of implanted cells in an in vivo tissue engineering model. Tissue Eng Part A 2012;18:2210-2219
14. Kehat I, Kenyagin-Karsenti D, Snir M, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001;108:407-414
15. Lim SY, Lee DG, Sivakumaran P et al. In vivo tissue engineering chamber supports human induced pluripotent stem cell survival and rapid differentiation. Biochem Biophys Res Commun 2012;422:75-79
16. Halbach M, Egert U, Hescheler J et al. Estimation of action potential changes from field potential recordings in multicellular mouse cardiac myocyte cultures. Cell Physiol Biochem 2003;13:271-284
17. Yoshida M, Kijima M, Akita M et al. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 1990;265:17174-17179
18. Karantzali E, Schulz H, Hummel O et al. Histone deacetylase inhibition accelerates the early events of stem cell differentiation: Transcriptomic and epigenetic analysis. Genome Biol 2008;9:R65
19. Lee JH, Hart SR, Skalnik DG. Histone deacetylase activity is required for embryonic stem cell differentiation. Genesis 2004;38:32-38
20. Karamboulas C, Swedani A, Ward C et al. HDAC activity regulates entry of mesoderm cells into the cardiac muscle lineage. J Cell Sci 2006;119:4305-4314
21. Hoxha E, Lambers E, Wasserstrom JA et al. Elucidation of a novel pathway through which HDAC1 controls cardiomyocyte differentiation through expression of SOX-17 and BMP2. PLoS One 2012;7:e45046
22. Hoxha E, Lambers E, Xie H et al. Histone deacetylase 1 deficiency impairs differentiation and electrophysiological properties of cardiomyocytes derived from induced pluripotent cells. STEM CELLS 2012;30:2412-2422
23. Otsuji TG, Kurose Y, Suemori H et al. Dynamic link between histone H3 acetylation and an increase in the functional characteristics of human ESC/iPSC-derived cardiomyocytes. PLoS One 2012;7:e45010
24. Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol 2005;23:845-856
25. Vunjak-Novakovic G, Lui KO, Tandon N et al. Bioengineering heart muscle: A paradigm for regenerative medicine. Annu Rev Biomed Eng 2011;13:245-267
26. Tiburcy M, Didie M, Boy O et al. Terminal differentiation, advanced organotypic maturation, and modeling of hypertrophic growth in engineered heart tissue. Circ Res 2011;109: 1105-1114
27. Morritt AN, Bortolotto SK, Dilley RJ et al. Cardiac tissue engineering in an in vivo vascularized chamber. Circulation 2007;115:353-360
28. Choi YS, Matsuda K, Dusting GJ et al. Engineering cardiac tissue in vivo from human adipose- derived stem cells. Biomaterials 2010; 31:2236-2242
29. Blazeski A, Zhu R, Hunter DW et al. Cardiomyocytes derived from human induced pluripotent stem cells as models for normal and diseased cardiac electrophysiology and contractility. Prog Biophys Mol Biol 2012;110: 166-177
30. Mehta A, Chung YY, Ng A et al. Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells. Cardiovasc Res 2011;91:577-586
31. Radisic M, Malda J, Epping E et al. Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol Bioeng 2006;93:332-343
32. Tee R, Morrison WA, Dusting GJ et al. Transplantation of engineered cardiac muscle flaps in syngeneic rats. Tissue Eng Part A 2012; 18:1992-1999.